Location

SCO 850, Shivalik Enclave, Sector 13, NAC Manimajra, Chandigarh - 160101
Call us:0172-5061850
Regd. Office:SCO 850, Shivalik Enclave, Sector 13, NAC Manimajra, Chandigarh - 160101

Our Business Verticals

Generic Healthcare Business

Research & Development

At Ind-Swift Group, our Research & Development (R&D) Center in Panchkula, Haryana, plays a crucial role in advancing innovative, cost-effective, and compliant pharmaceutical solutions. Recognized by DSIR since 1995, our R&D center supports global quality standards for developing novel formulations and processes.

Key Capabilities 

Our R&D division offers end-to-end contract research services, from early-stage development to dossier submission for global regulatory bodies.

Our Core Areas of Expertise:
  • Formulation Development across therapeutic categories like anti-diabetic, cardiovascular, CNS, and antibiotics

  • Bioequivalence & Bioavailability Studies in accordance with DCGI and international guidelines

  • Scale-Up & Technology Transfer Support for commercial manufacturing

  • Process Optimization and Technical Troubleshooting across manufacturing sites

Our R&D also provides strong regulatory support, including:
  • Preparation of dossiers for ANDAs, NDAs, and global regulatory submissions
  • Patent evaluations and filings
  • Documentation for USFDAbioequivalence samples, and commercial batches

Integrity in HealthcareA Commitment to Scientific Integrity and Patient Well-being

We are committed to:

  • Driving innovation in formulations and therapy approaches
  • Maintaining transparency and consistency in every step
  • Fostering long-term trust through scientific value and patient-centric solutions
  • Empowering our teams through continuous learning and leadership

The Ethical Business of Ind-Swift Laboratories Ltd. stands for more than product promotion – it represents our philosophy of “partnering with care.” With a commitment to clinical integrity and responsible communication, we aim to create long-term impact in the lives we touch.